glp-1 9 in 1 Glucagon-like peptide-1 cleavage product GLP-1(9–36) reduces neuroinflammation from stroke via the activation of insulin-like growth factor receptor astrocytes GLP-1 Hunger – Stark Pharmacy

A small observational study published in JCI Insight (2022) examined individuals with obesity receiving semaglutide who reported reductions in alcohol intake, though the relationship to weight loss requires further investigation in controlled trials

Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: A meta-analysis of clinical trials

This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease

For predictability, TrimRx delivers

In the CNS, GLP-1s may impact neuronal function in conditions, such as Alzheimer's disease and Parkinson's disease, through multiple mechanisms